Official title and information are available only for Plus and Premium subscribers.
Patent Granted Increased levels of the IGF-IR are expressed in the majority of primary and metastatic prostate cancer patient tumors.[6] Evidence suggests that IGF-IR signaling is required for survival and growth when prostate cancer cells progress to androgen independence.
To see the additional information details please login and subscribe to a Plus or Premium account.
